Pathologic Results of Radical Prostatectomies in Patients with Simultaneous Atypical Small Acinar Proliferation and Prostate Cancer

다국어 초록 (Multilingual Abstract)

Purpose: The incidence of adenocarcinoma on a subsequent biopsy following a diagnosis of atypical small acinar proliferation (ASAP) ranges from 34% to 60%. We reexamined radical prostatectomy (RP) specimens of patients diagnosed as having synchronous ASAP with prostate cancer (PCa) to evaluate pathological entities and the clinical significance of ASAP.
Materials and Methods: From January 2007 to December 2008, a total of 118 patients who had been diagnosed with adenocarcinoma on prostate needle biopsy underwent RP. Forty-six of the 118 patients (39%) were diagnosed as having synchronous ASAP with PCa on the prostate needle biopsy. Using whole-mount sections and prostate mapping, we evaluated the RP specimens that were close sections to the ASAP on prostate needle biopsy. All tissues were examined by immunohistochemistry with high molecular weight cytokeratin (34bE12), p63, and AMACR/P504S added to initial H&E stains by one pathologist.
Results: Thirty-six of the 46 patients (78%) were diagnosed as having adenocarcinoma at sites of ASAP on the initial prostate needle biopsies. The Gleason score was 5 to 6 in 22 patients (61%), 7 in 3 (8%), and unknown due to multifocal and microfocal lesions in 11 (31%). The tumor volume of 14 of the 36 patients (39%) was 0.5 cc or less and was unknown due to multifocal and microfocal lesions in 8 (22%).
Conclusions: Most ASAP on initial prostate needle biopsy was a true pathological entity, in other words, prostatic adenocarcinoma. Aggressive approaches including more extended repeat biopsy with additional biopsy of the site of the ASAP are needed to diagnose PCa in patients with ASAP.

다국어 초록 (Multilingual Abstract)

Purpose: The incidence of adenocarcinoma on a subsequent biopsy following a diagnosis of atypical small acinar proliferation (ASAP) ranges from 34% to 60%. We reexamined radical prostatectomy (RP) specimens of patients diagnosed as having synchronous ASAP with prostate cancer (PCa) to evaluate pathological entities and the clinical significance of ASAP.
Materials and Methods: From January 2007 to December 2008, a total of 118 patients who had been diagnosed with adenocarcinoma on prostate needle biopsy underwent RP. Forty-six of the 118 patients (39%) were diagnosed as having synchronous ASAP with PCa on the prostate needle biopsy. Using whole-mount sections and prostate mapping, we evaluated the RP specimens that were close sections to the ASAP on prostate needle biopsy. All tissues were examined by immunohistochemistry with high molecular weight cytokeratin (34bE12), p63, and AMACR/P504S added to initial H&E stains by one pathologist.
Results: Thirty-six of the 46 patients (78%) were diagnosed as having adenocarcinoma at sites of ASAP on the initial prostate needle biopsies. The Gleason score was 5 to 6 in 22 patients (61%), 7 in 3 (8%), and unknown due to multifocal and microfocal lesions in 11 (31%). The tumor volume of 14 of the 36 patients (39%) was 0.5 cc or less and was unknown due to multifocal and microfocal lesions in 8 (22%).
Conclusions: Most ASAP on initial prostate needle biopsy was a true pathological entity, in other words, prostatic adenocarcinoma. Aggressive approaches including more extended repeat biopsy with additional biopsy of the site of the ASAP are needed to diagnose PCa in patients with ASAP.

참고문헌 (Reference)

1 윤종현, "전립선암 진단에서 P504S와 34βE12 면역염색의 유용성" 대한비뇨기과학회 48 (48): 677-683, 2007

2 오정우, "전립선생검에서 비전형적작은꽈리증식증으로 진단된 환자의 재생검 결과" 대한비뇨기과학회 50 (50): 237-240, 2009

3 Jeldres C, "Validation of the contemporary epstein criteria for insignificant prostate cancer in European men" 54 : 1306-1313, 2008

4 Jiang Z, "Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens" 123 : 231-236, 2005

5 Epstein JI, "The pathological interpretation and significance of prostate needle biopsy findings: implications and current controversies" 166 : 402-410, 2001

6 Hodge KK, "Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate" 142 : 71-74, 1989

7 Vis AN, "Prostatic intraepithelial neoplasia and putative precursor lesions of prostate cancer: a clinical perspective" 88 : 147-157, 2001

8 Iczkowski KA, "Prostate cancer diagnosed after initial biopsy with atypical small acinar proliferation suspicious for malignancy is similar to cancer found on initial biopsy" 60 : 851-854, 2002

9 Park S, "Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy" 165 : 1409-1414, 2001

10 Mancuso PA, "Prostate cancer detection in men with an initial diagnosis of atypical small acinar proliferation" 99 : 49-52, 2007

11 Park SJ, "Predictors of prostate cancer on repeat transrectal ultrasound-guided systematic prostate biopsy" 10 : 68-71, 2003

12 Fadare O, "Practice patterns of clinicians following isolated diagnoses of atypical small acinar proliferation on prostate biopsy specimens" 128 : 557-560, 2004

13 Brausi M, "Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment?" 172 : 906-908, 2004

14 van Oort IM, "Hulsbergen-van de Kaa CA, Witjes JA. A single institution experience with biochemical recurrence after radical prostatectomy for tumors that on pathology are of small volume or "insignificant"" 27 : 509-513, 2009

15 Zhou M, "How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers?" 28 : 239-243, 2004

16 Schlesinger C, "High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation: predictive value for cancer in current practice" 29 : 1201-1207, 2005

17 Ploussard G, "High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation on initial 21-core extended biopsy scheme: incidence and implications for patient care and surveillance" 27 : 587-592, 2009

18 Ramey JR, "Further commentary: ultrasonography and biopsy of the prostate. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh urology. 9th ed" Saunders 2883-2895, 2007

19 Chan TY, "Follow-up of atypical prostate needle biopsies suspicious for cancer" 53 : 351-355, 1999

20 Elabbady AA, "Extended 12-core prostate biopsy increases both the detection of prostate cancer and the accuracy of Gleason score" 49 : 49-53, 2006

21 Bostwick DG, "Evaluating radical prostatectomy specimens: therapeutic and prognostic importance" 430 : 1-16, 1997

22 Matsumoto K, "Efficacy and morbidity of transrectal ultrasound-guided 12-core biopsy for detection of prostate cancer in Japanese men" 12 : 353-360, 2005

23 Iczkowski KA, "Diagnosis of "suspicious for malignancy" in prostate biopsies: predictive value for cancer" 51 : 749-757, 1998

24 Iczkowski KA, "Current prostate biopsy interpretation: criteria for cancer, atypical small acinar proliferation, high-grade prostatic intraepithelial neoplasia, and use of immunostains" 130 : 835-843, 2006

25 Allan RW, "Correlation of minute (0.5 MM or less) focus of prostate adenocarcinoma on needle biopsy with radical prostatectomy specimen: role of prostate specific antigen density" 170 : 370-372, 2003

26 Flury SC, "Atypical small acinar proliferation: biopsy artefact or distinct pathological entity?" 99 : 780-785, 2007

27 Samaratunga H, "Atypical prostatic glandular proliferations on needle biopsy: diagnostic implications, use of immunohistochemistry, and clinical significance" 28 : 104-110, 2006

28 Montironi R, "Atypical foci suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy")" 50 : 666-674, 2006

29 Bostwick DG, "Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma" 24 : 819-832, 1993

30 Lee SE, "Application of the Epstein criteria for prediction of clinically insignificant prostate cancer in Korean men"